Skip to main content
SpringerLink
Log in

Pharmacokinetic studies with PET

  • Chapter
Imaging in Drug Discovery and Early Clinical Trials

Part of the book series: Progress in Drug Research ((PDR,volume 62))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aboagye EO, Price PM, Jones T (2001) In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography. Drug Discov Today 6: 293–302

    Article  PubMed  CAS  Google Scholar 

  2. Fischman AJ, Alpert NM, Babich JW, Rubin RH (1997) The role of positron emission tomography in pharmacokinetic analysis. Drug Metab Rev 29: 923–956

    PubMed  CAS  Google Scholar 

  3. Fischman AJ, Alpert NM, Rubin RH (2002) Pharmacokinetic imaging: a noninvasive method for determining drug distribution and action. Clin Pharmacokinet 41: 581–602

    PubMed  CAS  Google Scholar 

  4. Gupta N, Price PM, Aboagye EO (2002) PET for in vivo pharmacokinetic and pharmacodynamic measurements. Eur J Cancer 38: 2094–2107

    Article  PubMed  CAS  Google Scholar 

  5. Hutchinson OC, Collingridge DR, Barthel H, Price PM, Aboagye EO (2003) Pharmacokinetics of radiolabeled anticancer drugs for positron emission tomography. Curr Pharm Des 9: 917–929

    PubMed  CAS  Google Scholar 

  6. Klimas MT (2002) Positron emission tomography and drug discovery: contributions to the understanding of pharmacokinetics, mechanism of action and disease state characterization. Mol Imaging Biol 4: 311–337

    PubMed  Google Scholar 

  7. Propper DJ, de Bono J, Saleem A, Ellard S, Flanagan E, Paul J, Ganesan TS, Talbot DC, Aboagye EO, Price P et al (2003) Use of positron emission tomography in pharmacokinetic studies to investigate therapeutic advantage in a phase I study of 120-hour intravenous infusion XR5000. J Clin Oncol 21: 203–210

    Article  PubMed  CAS  Google Scholar 

  8. Roselt P, Meikle S, Kassiou M (2004) The role of positron emission tomography in the discovery and development of new drugs; as studied in laboratory animals. Eur J Drug Metab Pharmacokinet 29: 1–6

    Article  PubMed  CAS  Google Scholar 

  9. Rubin RH, Fischman AJ (1997) Positron emission tomography in drug development. Q J Nucl Med 41: 171–175

    Google Scholar 

  10. Bergstrom M, Awad R, Estrada S, Malman J, Lu L, Lendvai G, Bergstrom-Pettermann E, Langstrom B (2003) Autoradiography with positron emitting isotopes in positron emission tomography tracer discovery. Mol Imaging Biol 5: 390–396

    PubMed  Google Scholar 

  11. Bergstrom M, Bonasera TA, Lu L, Bergstrom E, Backlin C, Juhlin C, Langstrom B (1998) In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors. J Nucl Med 39: 982–989

    PubMed  CAS  Google Scholar 

  12. Bergstrom M, Westerberg G, Langstrom B (1997) 11C-harmine as a tracer for monoamine oxidase A (MAO-A): in vitro and in vivo studies. Nucl Med Biol 24: 287–293

    PubMed  CAS  Google Scholar 

  13. Bergstrom M, Westerberg G, Kihlberg T, Langstrom B (1997) Synthesis of some 11CPharmacokinetic labeled MAO-A inhibitors and their in vivo uptake kinetics in rhesus monkey brain. Nucl Med Biol 24: p. 381–388

    PubMed  CAS  Google Scholar 

  14. Stahl M, Bouw R, Jackson A, Pay V (2002) Human microdialysis. Curr Pharm Biotechnol 3: 165–178

    Article  PubMed  CAS  Google Scholar 

  15. Ederoth P, Tunblad K, Bouw R, Lundberg CJ, Ungerstedt U, Nordstrom CH, Hammarlund-Udenaes M (2004) Blood-brain barrier transport of morphine in patients with severe brain trauma. Br J Clin Pharmacol 57: 427–435

    Article  PubMed  CAS  Google Scholar 

  16. Bielecka-Grzela S, Klimowicz A (2003) Application of cutaneous microdialysis to evaluate metronidazole and its main metabolite concentrations in the skin after a single oral dose. J Clin Pharm Ther 28: 465–469

    Article  PubMed  CAS  Google Scholar 

  17. Joukhadar C, Stass H, Muller-Zellenberg U, Lackner E, Kovar F, Minar E, Muller M (2003) Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans. Antimicrob Agents Chemother 47: 3099–3103

    Article  PubMed  CAS  Google Scholar 

  18. Joukhadar C, Klein N, Dittrich P, Zeitlinger M, Geppert A, Skhirtladze K, Frossard M, Heinz G, Muller M (2003) Target site penetration of fosfomycin in critically ill patients. J Antimicrob Chemother 51: 1247–1252

    Article  PubMed  CAS  Google Scholar 

  19. Langstrom B, Kihlberg T, Bergstrom M, Antoni G, Bjorkman M, Forngren BH, Forngren T, Hartvig P, Markides K, Yngve U, Ogren M (1999) Compounds labeled with short-lived beta(+)-emitting radionuclides and some applications in life sciences. The importance of time as a parameter. Acta Chem Scand 53: 651–669

    Article  PubMed  CAS  Google Scholar 

  20. Beshara S, Lundqvist H, Sundin J, Lubberink M, Tolmachev V, Valind S, Antoni G, Langstrom B, Danielson BG (1999) Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography. Br J Haematol 104: 296–302

    PubMed  CAS  Google Scholar 

  21. Fischman AJ, Livni E, Babich JW, Alpert NM, Bonab A, Chodosh S, McGovern F, Kamitsuka P, Liu YY, Cleeland R et al (1996) Pharmacokinetics of [18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography. Antimicrob Agents Chemother 40: 659–664

    PubMed  CAS  Google Scholar 

  22. Fischman AJ, Babich JW, Bonab AA, Alpert NM, Vincent J, Callahan RJ, Correia JA, Rubin RH (1998) Pharmacokinetics of [18F]trovafloxacin in healthy human subjects studied with positron emission tomography. Antimicrob Agents Chemother 42: 2048–2054

    PubMed  CAS  Google Scholar 

  23. Gulyas B, Halldin C, Karlsson P, Chou YH, Swahn CG, Bonock P, Paroczai M, Farde L (1999) Brain uptake and plasma metabolism of [11C]vinpocetine: a preliminary PET study in a cynomolgus monkey. J Neuroimaging 9: 217–222

    PubMed  CAS  Google Scholar 

  24. Gulyas B, Halldin C, Sandell J, Karlsson P, Sovago J, Karpati E, Kiss B, Vas A, Cselenyi Z, Farde L (2002) PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects. Acta Neurol Scand 106: 325–332

    Article  PubMed  CAS  Google Scholar 

  25. Islinger F, Bouw R, Stahl M, Lackner E, Zeleny P, Brunner M, Muller M, Eichler HG, Joukhadar C (2004) Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose. Antimicrob Agents Chemother 48: 4246–4249

    Article  PubMed  CAS  Google Scholar 

  26. Lee Z, Berridge MS, Finlay WH, Heald DL (2000) Mapping PET-measured triamcinolone acetonide (TAA) aerosol distribution into deposition by airway generation. Int J Pharm 199: 7–16

    Article  PubMed  CAS  Google Scholar 

  27. Matarrese M, Salimbeni A, Turolla EA, Turozzi D, Moresco RM, Poma D, Magni F, Todde S, Rossetti C, Sciarrone MT et al (2004) 11C-Radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]zofenoprilat. Bioorg Med Chem 12: 603–611

    PubMed  CAS  Google Scholar 

  28. Noda A, Takamatsu H, Murakami Y, Yajima K, Tatsumi M, Ichise R, Nishimura S (2003) Measurement of brain concentration of FK960 for development of a novel antidementia drug: a PET study in conscious rhesus monkeys. J Nucl Med 44: 105–108

    PubMed  CAS  Google Scholar 

  29. Osman S, Rowlinson-Busza G, Luthra SK, Aboagye EO, Brown GD, Brady F, Myers R, Gamage SA, Denny WA, Baguley BC, Price PM (2001) Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues. Cancer Res 61: 2935–2944

    PubMed  CAS  Google Scholar 

  30. Rubin RH, Livni E, Babich J, Alpert NM, Liu YY, Tham E, Prosser B, Cleeland R, Callahan RJ, Correia JA et al (1993) Pharmacokinetics of fleroxacin as studied by positron emission tomography and [18F]fleroxacin. Am J Med 94: 31S–37S

    PubMed  CAS  Google Scholar 

  31. Saleem A, Harte RJ, Matthews JC, Osman S, Brady F, Luthra SK, Brown GD, Bleehen N, Connors T, Jones T et al (2001) Pharmacokinetic evaluation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography. J Clin Oncol 19: 1421–1429

    PubMed  CAS  Google Scholar 

  32. Sanderson L, Taylor GW, Aboagye EO, Alao JP, Latigo JR, Coombes RC, Vigushin DM (2004) Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice. Drug Metab Dispos 32: 1132–1138

    Article  PubMed  CAS  Google Scholar 

  33. Bergstrom M, Nordberg A, Lunell E, Antoni G, Langstrom B (1995) Regional deposition of inhaled 11C-nicotine vapor in the human airway as visualized by positron emission tomography. Clin Pharmacol Ther 57: 309–317

    Article  PubMed  CAS  Google Scholar 

  34. Bergstrom M, Cass LM, Valind S, Westerberg G, Lundberg EL, Gray S, Bye A, Langstrom B (1999) Deposition and disposition of [11C]zanamivir following administration as an intranasal spray. Evaluation with positron emission tomography. Clin Pharmacokinet 36,Suppl 1: 33–39

    PubMed  CAS  Google Scholar 

  35. Berridge MS, Heald DL, Muswick GJ, Leisure GP, Voelker KW, Miraldi F (1998) Biodistribution and kinetics of nasal carbon-11-triamcinolone acetonide. J Nucl Med 39: 1972–1977

    PubMed  CAS  Google Scholar 

  36. Berridge MS, Lee Z, Heald DL (2000) Regional distribution and kinetics of inhaled pharmaceuticals. Curr Pharm Des 6: 1631–1651

    Article  PubMed  CAS  Google Scholar 

  37. Berridge MS, Lee Z, Heald DL (2000) Pulmonary distribution and kinetics of inhaled [11C]triamcinolone acetonide. J Nucl Med 41: 1603–1611

    PubMed  CAS  Google Scholar 

  38. Dolovich MB (2001) Measuring total and regional lung deposition using inhaled radiotracers. J Aerosol Med 14,Suppl 1: S35–S44

    PubMed  CAS  Google Scholar 

  39. Lee Z, Berridge MS (2002) PET imaging-based evaluation of aerosol drugs and their delivery devices: nasal and pulmonary studies. IEEE Trans Med Imaging 21: 1324–1331

    PubMed  Google Scholar 

  40. Pike VW, Aigbirhio FI, Freemantle CA, Page BC, Rhodes CG, Waters SL, Jones T, Olsson P, Ventresca GP, Tanner RJ et al (1995) Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting. Drug Metab Dispos 23: 832–839

    PubMed  CAS  Google Scholar 

  41. Nilsson D, Lennernas H, Fasth KJ, Sundin A, Tedroff J, Aquilonius SM, Hartvig P, Langstrom B (1999) Absorption of L-DOPA from the proximal small intestine studied in the rhesus monkey by positron emission tomography. Eur J Pharm Sci 7: 185–189

    Article  PubMed  CAS  Google Scholar 

  42. Gulyas B, Halldin C, Sovago J, Sandell J, Cselenyi Z, Vas A, Kiss B, Karpati E, Farde L (2002) Drug distribution in man: a positron emission tomography study after oral administration of the labeled neuroprotective drug vinpocetine. Eur J Nucl Med Mol Imaging 29: 1031–1038

    PubMed  CAS  Google Scholar 

  43. Lappin G, Garner RC (2003) Big physics, small doses: the use of AMS and PET in human microdosing of development drugs. Nat Rev Drug Discov 2: 233–240

    Article  PubMed  CAS  Google Scholar 

  44. Bergstrom M, Grahnen A, Langstrom B (2003) Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development. Eur J Clin Pharmacol 59: 357–366

    PubMed  Google Scholar 

  45. Meikle SR, Matthews JC, Brock CS, Wells P, Harte RJ, Cunningham VJ, Jones T, Price P (1998) Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: a feasibility study. Cancer Chemother Pharmacol 42: 183–193

    Article  PubMed  CAS  Google Scholar 

  46. Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ, Frackowiak RS (1996) Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab 16: 42–52

    PubMed  CAS  Google Scholar 

  47. Lammertsma AA, Bench CJ, Price GW, Cremer JE, Luthra SK, Turton D, Wood ND, Frackowiak RS (1991) Measurement of cerebral monoamine oxidase B activity using L-[11C]deprenyl and dynamic positron emission tomography. J Cereb Blood Flow Metab 11: 545–556

    PubMed  CAS  Google Scholar 

  48. Hume SP, Ashworth S, Opacka-Juffry J, Ahier RG, Lammertsma AA, Pike VW, Cliffe IA, Fletcher A, White AC (1994) Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain. Eur J Pharmacol 271: 515–523

    Article  PubMed  CAS  Google Scholar 

  49. Seltzer MA, Jahan SA, Sparks R, Stout DB, Satyamurthy N, Dahlbom M, Phelps ME, Barrio JR (2004) Radiation dose estimates in humans for (11)C-acetate whole-body PET. J Nucl Med 45: 1233–1236

    PubMed  CAS  Google Scholar 

  50. Tang G, Tang X, Wang M, Luo L, Gan M (2004) Radiation dosimetry of O-(3-[18F]fluoropropyl)-L-tyrosine as oncologic PET tracer based on the mice distribution data. Appl Radiat Isot 60: 27–32

    Article  PubMed  CAS  Google Scholar 

  51. Pauleit D, Floeth F, Herzog H, Hamacher K, Tellmann L, Muller HW, Coenen HH, Langen KJ (2003) Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine. Eur J Nucl Med Mol Imaging 30: 519–524

    Article  PubMed  CAS  Google Scholar 

  52. Marthi K, Hansen SB, Jakobsen S, Bender D, Smith SB, Smith DF (2003) Biodistribution and radiation dosimetry of [N-methyl-11C]mirtazapine, an antidepressant affecting adrenoceptors. Appl Radiat Isot 59: 175–179

    Article  PubMed  CAS  Google Scholar 

  53. Aboagye EO, Luthra SK, Brady F, Poole K, Anderson H, Jones T, Boobis A, Burtles SS, Price P (2002) Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for pre-phase I positron emission tomography studies in cancer patients. Br J Cancer 86: 1052–1056

    Article  PubMed  CAS  Google Scholar 

  54. Combes RD, Berridge T, Connelly J, Eve MD, Garner RC, Toon S, Wilcox P (2003) Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing. Eur J Pharm Sci 19: 1–11

    Article  PubMed  CAS  Google Scholar 

  55. Farde L, Hall H, Pauli S, Halldin C (1995) Variability in D2-dopamine receptor density and affinity: a PET study with [11C]raclopride in man. Synapse 20: 200–208

    Article  PubMed  CAS  Google Scholar 

  56. Bergstrom M, Fasth KJ, Kilpatrick G, Ward P, Cable KM, Wipperman MD, Sutherland DR, Langstrom B (2000) Brain uptake and receptor binding of two [11C]labeled selective high affinity NK1-antagonists, GR203040 and GR205171—PET studies in rhesus monkey. Neuropharmacology 39: 664–670

    PubMed  CAS  Google Scholar 

  57. Dobbs FR, Banks W, Fleishaker JC, Valentine AD, Kinsey BM, Franceschini MP, Digenis GA, Tewson TJ (1995) Studies with [11C]alprazolam: an agonist for the benzodiazepine receptor. Nucl Med Biol 22: 459–466

    PubMed  CAS  Google Scholar 

  58. Lahteenmaki P, Heikinheimo O, Croxatto H, Spitz I, Shoupe D, Birgerson L, Luukkainen T (1987) Pharmacokinetics and metabolism of RU 486. J Steroid Biochem 27: 859–863

    Article  PubMed  CAS  Google Scholar 

  59. Elsinga PH, Franssen EJ, Hendrikse NH, Fluks L, Weemaes AM, van der Graaf WT, de Vries EG, Visser GM, Vaalburg W (1996) Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET. J Nucl Med 37: 1571–1575

    PubMed  CAS  Google Scholar 

  60. Elsinga PH, Hendrikse NH, Bart J, Vaalburg W, van Waarde A (2004) PET Studies on Pglycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS. Curr Pharm Des 10: 1493–1503

    Article  PubMed  CAS  Google Scholar 

  61. Kurdziel KA, Kiesewetter DO, Carson RE, Eckelman WC, Herscovitch P (2003) Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of 18F-paclitaxel in nonhuman primates. J Nucl Med 44: 1330–1339

    PubMed  CAS  Google Scholar 

  62. Sundin A, Eriksson B, Bergstrom M, Bjurling P, Lindner KJ, Oberg K, Langstrom B (2000) Demonstration of [11C] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography. Nucl Med Biol 27: 33–41

    Article  PubMed  CAS  Google Scholar 

  63. Bergstrom M, Eriksson B, Oberg K, Sundin A, Ahlstrom H, Lindner KJ, Bjurling P, Langstrom B (1996) In vivo demonstration of enzyme activity in endocrine pancreatic tumors: decarboxylation of carbon-11-DOPA to carbon-11-dopamine. J Nucl Med 37: 32–37

    PubMed  CAS  Google Scholar 

  64. Saleem A, Brown GD, Brady F, Aboagye EO, Osman S, Luthra SK, Ranicar AS, Brock CS, Stevens MF, Newlands E et al (2003) Metabolic activation of temozolomide measured in vivo using positron emission tomography. Cancer Res 63: 2409–2415

    PubMed  CAS  Google Scholar 

  65. Luurtsema G, de Lange EC, Lammertsma AA, Franssen EJ (2004) Transport across the blood-brain barrier: stereoselectivity and PET-tracers. Mol Imaging Biol 6: 306–318

    PubMed  Google Scholar 

  66. Rahman O, Kihlberg T, Langstrom B (2004) Synthesis of [11C]/(13C)amines via carbonylation followed by reductive amination. Org Biomol Chem 2: 1612–1616

    PubMed  CAS  Google Scholar 

  67. Itsenko O, Kihlberg T, Langstrom B (2004) Photoinitiated carbonylation with [(11)C]carbon monoxide using amines and alkyl iodides. J Org Chem 69: 4356–4360

    Article  PubMed  CAS  Google Scholar 

  68. Karimi F, Langstrom B (2003) Synthesis of 11C-amides using [11C]carbon monoxide and in situ activated amines by palladium-mediated carboxaminations. Org Biomol Chem 1: 541–546

    Article  PubMed  CAS  Google Scholar 

  69. Kihlberg T, Karimi F, Langstrom B (2002) [(11)C] Carbon monoxide in selenium-mediated synthesis of (11)C-carbamoyl compounds. J Org Chem 67: 3687–3692

    Article  PubMed  CAS  Google Scholar 

  70. Rahman O, Kihlberg T, Langstrom B (2003) Aryl triflates and [11C]/(13C)carbon monoxide in the synthesis of 11C-/13C-amides. J Org Chem 68: 3558–3562

    Article  PubMed  CAS  Google Scholar 

  71. Farde L, Ginovart N, Ito H, Lundkvist C, Pike VW, McCarron JA, Halldin C (1997) PETcharacterization of [carbonyl-11C]WAY-100635 binding to 5-HT1A receptors in the primate brain. Psychopharmacology (Berl) 133: 196–202

    CAS  Google Scholar 

  72. Olsson H, Halldin C, Farde L (2004) Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET. Neuroimage 22: 794–803

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Uppsala Imanet, GE Health Care Box 967, SE-751 09, Uppsala, Sweden

    Mats Bergström & Bengt Långström

  2. Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden

    Mats Bergström

  3. Department of Organic Chemistry, Uppsala University, Uppsala, Sweden

    Bengt Långström

Authors
  1. Mats Bergström
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bengt Långström
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute for Biomedical Engineering, University of Zürich/ETH Zürich, Moussonstr. 18, CH - 8092, Zürich, Switzerland

    Markus Rudin

  2. Novartis International AG, CH-4002, Basel, Switzerland

    Paul L. Herrling

  3. Novartis Institute for Tropical Diseases, 10 Biopolis Road, #05-01 Chromos, Singapore, 138670, Singapore

    Alex Matter M.D. (Director) (Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Birkhäuser Verlag, Basel (Switzerland)

About this chapter

Cite this chapter

Bergström, M., Långström, B. (2005). Pharmacokinetic studies with PET. In: Herrling, P.L., Matter, A., Rudin, M. (eds) Imaging in Drug Discovery and Early Clinical Trials. Progress in Drug Research, vol 62. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7426-8_8

Download citation

Publish with us

Policies and ethics

Search

Navigation